Abstract

This presentation was given at the ACIP extraordinary meeting on January 27th.

It includes an update on

  • AZD1222 Adenoviral Platform, Clinical Development Plan & Phase I/II
  • Data US Phase III Study
  • Non-IND Phase III Efficacy and Safety Trials (Interim Analysis)
  • Vaccine Storage & Handling
  • Summary
  • Background paper
  • Americas
  • United States of America
  • AstraZeneca COVID-19 vaccine
  • COVID-19